1. Home
  2. ORC vs MLYS Comparison

ORC vs MLYS Comparison

Compare ORC & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orchid Island Capital Inc.

ORC

Orchid Island Capital Inc.

HOLD

Current Price

$7.36

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$35.86

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORC
MLYS
Founded
2010
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
3.1B
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
ORC
MLYS
Price
$7.36
$35.86
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
$7.50
$47.33
AVG Volume (30 Days)
6.2M
1.5M
Earning Date
01-29-2026
02-11-2026
Dividend Yield
19.54%
N/A
EPS Growth
N/A
N/A
EPS
0.57
N/A
Revenue
$80,187,000.00
N/A
Revenue This Year
$90.64
N/A
Revenue Next Year
$78.88
N/A
P/E Ratio
$12.84
N/A
Revenue Growth
5.93
N/A
52 Week Low
$5.69
$8.24
52 Week High
$9.01
$47.65

Technical Indicators

Market Signals
Indicator
ORC
MLYS
Relative Strength Index (RSI) 55.74 39.18
Support Level $7.28 $35.01
Resistance Level $7.40 $37.75
Average True Range (ATR) 0.13 1.56
MACD 0.00 0.00
Stochastic Oscillator 66.28 20.77

Price Performance

Historical Comparison
ORC
MLYS

About ORC Orchid Island Capital Inc.

Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: